Clinical Trial Update: Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating vitamin K to reduce coronary artery calcification in patients with end-stage kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Drugs mentioned

• Vitamin K (Vitamin K)

Snippet

Sponsor: Dr. Rachel Holden | Conditions: End-stage Kidney Disease | Phase 2 | Status: COMPLETED